These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 16319057)
1. The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63. Helton ES; Zhu J; Chen X J Biol Chem; 2006 Feb; 281(5):2533-42. PubMed ID: 16319057 [TBL] [Abstract][Full Text] [Related]
2. The proline-rich domain in p63 is necessary for the transcriptional and apoptosis-inducing activities of TAp63. Helton ES; Zhang J; Chen X Oncogene; 2008 May; 27(20):2843-50. PubMed ID: 18037962 [TBL] [Abstract][Full Text] [Related]
3. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Dohn M; Zhang S; Chen X Oncogene; 2001 May; 20(25):3193-205. PubMed ID: 11423969 [TBL] [Abstract][Full Text] [Related]
4. DNA-binding and transactivation activities are essential for TAp63 protein degradation. Ying H; Chang DL; Zheng H; McKeon F; Xiao ZX Mol Cell Biol; 2005 Jul; 25(14):6154-64. PubMed ID: 15988026 [TBL] [Abstract][Full Text] [Related]
5. TA-p63-gamma regulates expression of DeltaN-p63 in a manner that is sensitive to p53. Li N; Li H; Cherukuri P; Farzan S; Harmes DC; DiRenzo J Oncogene; 2006 Apr; 25(16):2349-59. PubMed ID: 16331262 [TBL] [Abstract][Full Text] [Related]
6. The promyelocytic leukaemia protein tumour suppressor functions as a transcriptional regulator of p63. Bernassola F; Oberst A; Melino G; Pandolfi PP Oncogene; 2005 Oct; 24(46):6982-6. PubMed ID: 16007146 [TBL] [Abstract][Full Text] [Related]
7. One, two, three--p53, p63, p73 and chemosensitivity. Müller M; Schleithoff ES; Stremmel W; Melino G; Krammer PH; Schilling T Drug Resist Updat; 2006 Dec; 9(6):288-306. PubMed ID: 17287142 [TBL] [Abstract][Full Text] [Related]
8. Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis. King KE; Ponnamperuma RM; Gerdes MJ; Tokino T; Yamashita T; Baker CC; Weinberg WC Carcinogenesis; 2006 Jan; 27(1):53-63. PubMed ID: 16081516 [TBL] [Abstract][Full Text] [Related]
9. Novel in vivo targets of DeltaNp63 in keratinocytes identified by a modified chromatin immunoprecipitation approach. Birkaya B; Ortt K; Sinha S BMC Mol Biol; 2007 May; 8():43. PubMed ID: 17521434 [TBL] [Abstract][Full Text] [Related]
10. A functional enhancer of keratin14 is a direct transcriptional target of deltaNp63. Romano RA; Birkaya B; Sinha S J Invest Dermatol; 2007 May; 127(5):1175-86. PubMed ID: 17159913 [TBL] [Abstract][Full Text] [Related]
11. Frequent alteration of p63 expression in human primary bladder carcinomas. Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040 [TBL] [Abstract][Full Text] [Related]
12. DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Wu G; Nomoto S; Hoque MO; Dracheva T; Osada M; Lee CC; Dong SM; Guo Z; Benoit N; Cohen Y; Rechthand P; Califano J; Moon CS; Ratovitski E; Jen J; Sidransky D; Trink B Cancer Res; 2003 May; 63(10):2351-7. PubMed ID: 12750249 [TBL] [Abstract][Full Text] [Related]
13. Defining the regulatory elements in the proximal promoter of DeltaNp63 in keratinocytes: Potential roles for Sp1/Sp3, NF-Y, and p63. Romano RA; Birkaya B; Sinha S J Invest Dermatol; 2006 Jul; 126(7):1469-79. PubMed ID: 16645595 [TBL] [Abstract][Full Text] [Related]
14. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck. Boldrup L; Coates PJ; Gu X; Nylander K J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional activity of the DeltaNp63 promoter is regulated by STAT3. Chu WK; Dai PM; Li HL; Chen JK J Biol Chem; 2008 Mar; 283(12):7328-37. PubMed ID: 18198175 [TBL] [Abstract][Full Text] [Related]
16. ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis. Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H PLoS One; 2019; 14(4):e0214867. PubMed ID: 30973901 [TBL] [Abstract][Full Text] [Related]
17. Regulation of limbal keratinocyte proliferation and differentiation by TAp63 and DeltaNp63 transcription factors. Wang DY; Cheng CC; Kao MH; Hsueh YJ; Ma DH; Chen JK Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3102-8. PubMed ID: 16123408 [TBL] [Abstract][Full Text] [Related]
18. Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains. Ghioni P; Bolognese F; Duijf PH; Van Bokhoven H; Mantovani R; Guerrini L Mol Cell Biol; 2002 Dec; 22(24):8659-68. PubMed ID: 12446784 [TBL] [Abstract][Full Text] [Related]
19. TAp63 and DeltaNp63 in cancer and epidermal development. Candi E; Dinsdale D; Rufini A; Salomoni P; Knight RA; Mueller M; Krammer PH; Melino G Cell Cycle; 2007 Feb; 6(3):274-85. PubMed ID: 17264681 [TBL] [Abstract][Full Text] [Related]
20. Itch/AIP4 associates with and promotes p63 protein degradation. Rossi M; De Simone M; Pollice A; Santoro R; La Mantia G; Guerrini L; Calabrò V Cell Cycle; 2006 Aug; 5(16):1816-22. PubMed ID: 16861923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]